Healthcare & Pharmaceutical
Indonesia is poised to become a key market of growth in this region for the healthcare industry. National healthcare expenditure has grown significantly over recent years from $7.2bn in 2005 to $18.3bn in 2010; and pharmaceutical sales are expected to grow robustly in 2012-16 at a compound annual growth rate (CAGR) of 11.5 per cent in local currency terms.
Currently our students have been involved in;
- Assisting a Neuro Psychology clinic with the treatment of autistic children
- Assisting clients of a Medical consultant and distribution company to enter into Indonesia
- Pharmaceutical product registrations at the Indonesian FDA.
- Provision of appropriate care to relevant patients in day surgery, medical imaging and endoscopy.
- The ongoing plan of Indonesia's Ministry of Health to provide healthcare insurance for over half of the
country's population through a universal social security system.
- The governments's planning is that poorer people will have their premiums paid by the government, while the
others would pay for the insurance fees themselves.
- Foreign pharmaceutical companies often find themselves facing strong competition from local manufacturers
of low-cost generics.
- The distribution of Pharmaceutical products accross the thousands of Islands make the market access very
- The private sector accounts for 40 percent of hospitals in Indonesia, and growth is expected to continue.